NANONanobiotixNANO info
$5.27info6.38%24h
Global rank15957
Market cap$248.10M
Change 7d0.81%
YTD Performance-29.49%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Business data

    Nanobiotix (NANO) Stock Overview

    Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.

    NANO Stock Information

    Symbol
    NANO
    Address
    60 rue de WattigniesParis, 75012France
    Founded
    -
    Trading hours
    -
    Website
    https://www.nanobiotix.com
    Country
    πŸ‡«πŸ‡· France
    Phone Number
    33 1 40 26 04 70

    Nanobiotix (NANO) Price Chart

    -
    Value:-

    Nanobiotix Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $5.27
    N/A
    Market Cap
    $248.10M
    N/A
    Shares Outstanding
    47.11M
    N/A
    Employees
    101.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org